194 related articles for article (PubMed ID: 26463250)
1. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
Kumar B; Baldi A
Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
[TBL] [Abstract][Full Text] [Related]
2. Counterfeit pharmaceuticals: current status and future projections.
Wertheimer AI; Chaney NM; Santella T
J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
[TBL] [Abstract][Full Text] [Related]
3. Understanding and fighting the medicine counterfeit market.
Dégardin K; Roggo Y; Margot P
J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
[TBL] [Abstract][Full Text] [Related]
4. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
6. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
[TBL] [Abstract][Full Text] [Related]
7. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
Liberman J
J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
9. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
Pashkov V; Soloviov A; Olefir A
Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
[TBL] [Abstract][Full Text] [Related]
10. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
Hurtado RL; Lasmar MC
Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
[TBL] [Abstract][Full Text] [Related]
11. Health risks of counterfeit pharmaceuticals.
ten Ham M
Drug Saf; 2003; 26(14):991-7. PubMed ID: 14583061
[TBL] [Abstract][Full Text] [Related]
12. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
Mackey TK; Liang BA
BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
[TBL] [Abstract][Full Text] [Related]
13. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
[TBL] [Abstract][Full Text] [Related]
14. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.
Koczwara A; Dressman J
J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909
[TBL] [Abstract][Full Text] [Related]
15. [Counterfeit and Falsified Drugs: an Overview].
Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
[TBL] [Abstract][Full Text] [Related]
16. Counterfeit drugs: defining the problem and finding solutions.
Wertheimer AI; Santella TM
Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.
Mackey TK; Liang BA
Global Health; 2013 Oct; 9():45. PubMed ID: 24131576
[TBL] [Abstract][Full Text] [Related]
18. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
Nsimba SE
East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
[TBL] [Abstract][Full Text] [Related]
19. Forensic intelligence for medicine anti-counterfeiting.
Dégardin K; Roggo Y; Margot P
Forensic Sci Int; 2015 Mar; 248():15-32. PubMed ID: 25576676
[TBL] [Abstract][Full Text] [Related]
20. [The role of German official medicines control laboratories in combating counterfeit medicines].
Wiegard A; Heuermann M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
